Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.15B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.3B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$831M |
| 4 |
Microsoft
MSFT
|
+$763M |
| 5 |
NVIDIA
NVDA
|
+$665M |
Top Sells
Sector Composition
| 1 | Technology | 24.59% |
| 2 | Financials | 11.81% |
| 3 | Healthcare | 9.32% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Generation Bio
GBIO
$39.3M
| $75.8K | ﹤0.01% |
23,686
-11,958
| -34% | -$38.3K |
|
3427
Acrivon Therapeutics
ACRV
$51.9M
| $75.7K | ﹤0.01% |
63,636
-47,684
| -43% | -$56.7K |
|
3428
Lightpath Technologies
LPTH
$233M
| $74.5K | ﹤0.01% |
24,173
| – | – |
|
3429
Genelux
GNLX
$134M
| $71.8K | ﹤0.01% |
25,000
| – | – |
|
3430
Intellicheck
IDN
$112M
| $69.9K | ﹤0.01% |
12,962
| – | – |
|
|
VXRT
3431
DELISTED
Vaxart
VXRT
| $69.5K | ﹤0.01% |
153,847
+300
| +0.2% | +$136 |
|
|
AGEN
3432
Agenus
AGEN
$136M
| $68.8K | ﹤0.01% |
15,061
-48,624
| -76% | -$222K |
|
3433
GoHealth
GOCO
$75.8M
| $66.9K | ﹤0.01% |
12,060
-3,311
| -22% | -$18.4K |
|
3434
InfuSystem Holdings
INFU
$213M
| $66.5K | ﹤0.01% |
10,655
-46,723
| -81% | -$292K |
|
3435
Atossa Therapeutics
ATOS
$104M
| $66.4K | ﹤0.01% |
80,000
-342,582
| -81% | -$284K |
|
|
SBC
3436
SBC Medical Group Holdings Incorporated Common Stock
SBC
$512M
| $66.2K | ﹤0.01% |
+14,267
| New | +$66.2K |
|
3437
Prelude Therapeutics
PRLD
$70.8M
| $65.4K | ﹤0.01% |
80,845
-33,205
| -29% | -$26.9K |
|
3438
RenovoRx
RNXT
$41.8M
| $65K | ﹤0.01% |
49,232
| – | – |
|
3439
Lineage Cell Therapeutics
LCTX
$290M
| $62K | ﹤0.01% |
68,275
-434,918
| -86% | -$395K |
|
3440
Ondas Holdings
ONDS
$1.52B
| $61.4K | ﹤0.01% |
32,000
| – | – |
|
3441
NN Inc
NNBR
$126M
| $59.6K | ﹤0.01% |
28,401
-108,301
| -79% | -$227K |
|
3442
Verde Clean Fuels
VGAS
$63.1M
| $58.9K | ﹤0.01% |
+17,113
| New | +$58.9K |
|
3443
Coya Therapeutics
COYA
$107M
| $57.5K | ﹤0.01% |
10,000
| – | – |
|
3444
Full House Resorts
FLL
$120M
| $55.8K | ﹤0.01% |
15,255
-80,111
| -84% | -$293K |
|
3445
ALX Oncology
ALXO
$59.4M
| $55.4K | ﹤0.01% |
133,433
-77,618
| -37% | -$32.2K |
|
|
ATLN
3446
Atlantic International Corp. Common Stock
ATLN
$189M
| $54.2K | ﹤0.01% |
+26,705
| New | +$54.2K |
|
|
TWNP
3447
Twin Hospitality Group Inc. Class A Common Stock
TWNP
$240M
| $53.2K | ﹤0.01% |
11,772
| – | – |
|
3448
Marchex
MCHX
$89.2M
| $52.5K | ﹤0.01% |
24,313
| – | – |
|
3449
Amplify Energy
AMPY
$151M
| $52.4K | ﹤0.01% |
16,376
-96,966
| -86% | -$310K |
|
3450
DHI Group
DHX
$143M
| $52.3K | ﹤0.01% |
17,605
| – | – |
|